MedTrace Logo

Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

NCT03345069 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 393

Last updated 2024-02-07

No results posted yet for this study

Summary

The Early Prediction Study is a longitudinal population-based cohort study for very preterm infants ≤32 weeks gestational age. Preterm infants recruited from three greater Cincinnati and two Dayton area neonatal intensive care units (NICUs) will undergo advanced MRIs at 41 weeks postmenstrual age and neurodevelopmental testing at the corrected ages of two and three years correct age. The goal of the Early Prediction Study is to accurately predict motor, cognitive, and behavioral deficits in individual very preterm infants using neuroimaging technologies and established epidemiologic approaches.

Conditions

  • Premature Infant

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • Good Samaritan Hospital, Ohio

    collaborator OTHER

  • Kettering Health Network

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Nehal A Parikh, DO, MS · Children's Hospital Medical Center, Cincinnati

Eligibility

Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-16
Primary Completion
2024-12-31
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03345069 on ClinicalTrials.gov